Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Breast 1

Conditions

Ovarian Neoplasms 4Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Sarcoma 1Neoplasm Invasiveness 1Myofibroma 1Hereditary Breast and Ovarian Cancer Syndrome 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Disease 1Carcinoma, Ovarian Epithelial 1

Interventions

Surveys and Questionnaires 6Methods 6Radiotherapy 5Cisplatin 5pembrolizumab 4durvalumab 3Sentinel Lymph Node Biopsy 3Radiosurgery 3Palliative Care 3Indocyanine Green 3Early Intervention, Educational 3Brachytherapy 3Bleomycin 3tremelimumab 2aldesleukin 2Surgical Procedures, Operative 2Radiation 2Paclitaxel 2Interviews as Topic 2Immunoglobulin G 2Imiquimod 2Gemcitabine 2Electrochemotherapy 2Drug Therapy 2Disulfides 2Dehydroepiandrosterone 2Counseling 2Carboplatin 2Biopsy 2Bevacizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Vulvar Neoplasms × CA-125 Antigen × Clear all
NCT00005095 2025-02-28

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Northwestern University

Recruiting
6,000 enrolled
BreastGynecologicSarcoma

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Sarcoma, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Myofibroma, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡